Abstract
People with cancer, who have taken antibiotics in the year before starting therapy with immune checkpoint inhibitors (ICIs), have a reduced chance of the therapy working and a lower chance of survival, research suggests. A Canadian cohort study looked at records from 2,737 people who had taken ICIs for cancer between June 2012 and October 2018. […]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
